Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Paracetamol 50 mg/mL Suspension, oral Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Amcal Paracetamol Pain and Fever Relief Component 1: Ranitidine hydrochloride 336 mg equivalent to 300 mg ranitidine Tablet, film coated Genpharm Inc. Pharmaceuticals, Etobicoke, Ontario, Canada Pacific Triple Pack Component 2: Metronidazole 400 mg Tablet Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia; and Pacific Pharmaceuticals Limited, Mount Wellington, Auckland Component 3: Amoxycillin trihydrate 287 mg equivalent to 250 mg amoxycillin Capsule, powder filled Pacific Pharmaceuticals Limited, Mount Wellington, Auckland Prednisolone sodium phosphate 6.72 mg/mL equivalent to 5 mg/mL prednisolone Solution, oral Sigma Pharmaceuticals Pty Limited, Clayton, Victoria, Australia Redipred Mirtazapine 15 mg, 30 mg, 45 mg Tablet, film coated N V Organon, Oss, The Netherlands; and Riom Laboratories CERM, Zone Industrielle ``Le Malcourlet'', Gannat, France Remeron Sodium citrate (dihydrate) 300 mmol/L Solution, oral McGaw Biomed Limited; Point Chevalier, Auckland Sodium Citrate Oral Mixture Dated this 30th day of April 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.